首页> 外国专利> ARYL- OR BENZO-IMIDAZOAZEPINE DERIVATIVES {TYPICALLY 7,10-DIHYDRO-7-METHYL-10-(1-METHYL-4-PIPERIDINYLIDENE)IMIDA ZO1,2-APYRROLO3,2-D-AZEPIN-6(5H)-ONE}; INTERMEDIATES INCLUDING 1-ESTERIFIED-2-DISUBSTITUTEDMETHYL-1H-IMIDAZOLE

ARYL- OR BENZO-IMIDAZOAZEPINE DERIVATIVES {TYPICALLY 7,10-DIHYDRO-7-METHYL-10-(1-METHYL-4-PIPERIDINYLIDENE)IMIDA ZO1,2-APYRROLO3,2-D-AZEPIN-6(5H)-ONE}; INTERMEDIATES INCLUDING 1-ESTERIFIED-2-DISUBSTITUTEDMETHYL-1H-IMIDAZOLE

机译:芳基或苯并咪唑啉衍生物{通常为7,10-二氢-7-甲基-10-(1-甲基-4-哌啶基)咪唑ZO [1,2-A]吡咯并[3,2-D] -AZEPIN- 6(5H)-ONE};中间体,包括1-酯化2- [二取代甲基-1H-咪唑

摘要

PCT No. PCT/EP94/02287 Sec. 371 Date Dec. 13, 1995 Sec. 102(e) Date Dec. 13, 1995 PCT Filed Jul. 6, 1994 PCT Pub. No. WO95/02600 PCT Pub. Date Jan. 26, 1995The present invention is concerned with novel imidazoazepines of formula IMAGE (I) the pharmaceutically acceptable addition salts and stereochemically isomeric forms thereof, wherein each of the dotted lines independently represents an optional bond; -A-B- is a radical of formula -X-CH=CH- (a-1); -CH=CH-X- (a-2); or -CH=CH- CH=CH- (a-3); X represents O, S or NR1; R1 represents hydrogen or C1-6alkyl; +E,ovs -----+EE Y is a radical of formula =O (b-1); -OH (b-2); or =N-OH (b-3); and L represents hydrogen, C1-4alkylcarbonyl, C1-4alkyloxycarbonyl, phenylcarbonyl, C1-6alkyl or C1-6alkyl substituted with C1-4alkyloxycarbonyl, hydroxycarbonyl, aryl, aryloxy or a radical of formula IMAGE (c) -D-Z- is -S-CH=CH-, -S-CH2-CH2-, -S-CH2-CH2-CH2-, -CH=CH-CH=CH- or -CH2-CH2-CH2-CH2-; and aryl is phenyl or phenyl substituted with halo, hydroxy or C1-4alkyloxy. Compositions comprising said compounds, processes for preparing the same and the use of these compounds for treating allergic diseases.
机译:PCT号PCT / EP94 / 02287第二部分371日期1995年12月13日第102(e)日期1995年12月13日PCT 1994年7月6日提交PCT Pub。 WO95 / 02600 PCT公开1995年1月26日,本发明涉及式的新型咪唑并azo庚因:(I)其药学上可接受的加成盐和立体化学异构体形式,其中每个虚线独立地代表任选的键; -A-B-是式-X-CH = CH-(a-1)的基团; -CH = CH-X-(a-2);或-CH = CH- CH = CH-(a-3); X代表O,S或NR1; R1代表氢或C1-6烷基; + E,ovs ----- + EE Y是一个公式= O(b-1)的根; -OH(b-2);或= N-OH(b-3); L表示氢,C 1-4烷基羰基,C 1-4烷氧基羰基,苯基羰基,C 1-6烷基或被C 1-4烷氧基羰基,羟基羰基,芳基,芳氧基或式的基团取代的C 1-6烷基。(c)-DZ-为-S -CH = CH-,-S-CH2-CH2-,-S-CH2-CH2-CH2-,-CH = CH-CH = CH-或-CH2-CH2-CH2-CH2-;芳基是苯基或被卤素,羟基或C 1-4烷氧基取代的苯基。包含所述化合物的组合物,其制备方法以及这些化合物在治疗过敏性疾病中的用途。

著录项

  • 公开/公告号NZ271071A

    专利类型

  • 公开/公告日1996-08-27

    原文格式PDF

  • 申请/专利权人 JANSSEN PHARMACEUTICA NV;

    申请/专利号NZ19940271071

  • 申请日1994-07-06

  • 分类号C07D487/14;C07D487/04;C07D491/14;C07D495/14;C07D519/00;A61K31/55;C07D401/14;C07D405/14;C07D409/14;C07D401/06;

  • 国家 NZ

  • 入库时间 2022-08-22 03:53:02

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号